UTEK Corporation (UTK) is a leader in the open innovation and technology transfer markets. They offer advanced research and development services for companies, and help colleges and universities receive fair compensation for their intellectual property. Their primary objective is to help companies identify and acquire technologies primarily developed by universities, medical centers, and federal research laboratories in the United States, the United Kingdom, and Israel. The company, which has been in operation for twelve years, and publicly traded on the AMEX exchange for the past six years, also provides tools to search, analyze, and manage university intellectual properties.

Its University to Business (U2B) process supports publicly traded firms in various industries to acquire university discoveries in exchange for their equity securities. They operate in two different types of intellectual property: physical sciences and life sciences. More specifically, the company has broken those two types into nine successful divisions. Physical science is broken down into Energy and Environmental, Homeland Defense and Safety, Software and Communications, Material Sciences, and Miscellaneous. Life science is broken down into Medical Devices, Medical Imaging and Diagnostics, Nutraceutical and Nutritional Supplements, Drug Delivery, Disease Treatments and Therapeutics.

The company finished 2007 with over $20.3 million in total revenues, which was on par with estimates. The 2007 revenues translated to an impressive $6.5 million in EBITDA. UTEK also maintains an impressive balance sheet that shows more than $5.2 million in cash on hand and a current ratio of 7.57, well above other key competitors in the R&D industry. The company has a promising future, and – according to the client testimonies on their website – is not only meeting, but exceeding customer expectations.

Let us hear your thoughts: UTEK Corp. Message Board